Finance entity
All 1 tracked stories fall under one category: markets. Charles River Laboratories is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 3 original sources each. IQVIA Holdings appears in 1 tracked Finance story from June 19, 2026.
Last mentioned: Jun 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: markets. Charles River Laboratories is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 3 original sources each. IQVIA Holdings appears in 1 tracked Finance story from June 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 19 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering IQVIA Holdings. Shared-story counts are live from our verified record — not editorial picks.
Morgan Stanley’s June 17 split decision on CRL and IQV reshapes CRO stock valuations. The upgrade to Overweight on Charles River and downgrade of IQVIA reflect a diverging view on exposure to the biotech capital cycle, with clear price target adjustments and implications for sector rotation.
IQVIA Holdings is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
